Committed to therapeutic progress to serve patient needs
Servier is a global pharmaceutical company dedicated to serving health and committed to therapeutic progress, addressing patient needs worldwide. As a group governed by a Foundation, Servier aspires to have a meaningful social impact, focusing on both patients and a sustainable world. With a unique governance model, Servier is deeply committed to its vocation with a long-term vision.
With over 21,900 employees, Servier is a world leader in cardiology and aims to be an innovative player in oncology, targeting hard-to-treat cancers. Over 70% of Servier's R&D budget is allocated to developing targeted and innovative therapies in oncology. Neuroscience and immuno-inflammatory diseases are future growth drivers, with a focus on precision medicine through accurate patient profiling. Servier is headquartered in France and maintains a strong geographical presence in over 150 countries. The primary address is 50 rue Carnot, Suresnes, 92150, FR.
Servier is also dedicated to promoting access to quality care for all, offering a range of quality generic drugs covering most pathologies, with strong brands in France, Eastern Europe, Brazil, and Nigeria. In all areas, Servier includes the patient voice at each stage of a medicine's life cycle. In 2023, Servier achieved a revenue of €5.3 billion, reflecting its global impact and dedication to healthcare. We invite the manager of Servier to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility.
Other organizations in the same industry
This company is also known as